Astra doubles share buy-back

Friday, 30. July 2010

Astra is facing a tougher second half due to generic competition and the absence of a contribution from the pandemic flu vaccine, making for tough
See all stories on this topic ยป

View more on Google Alerts – “flu vaccine”

Comments are closed.